UTEK Corporation and In Veritas Medical Diagnostics announce strategic
alliance21 August 2006
Tampa, Fla., USA & Inverness, Scotland. UTEK
Corporation (AMEX:UTK) (LSE-AIM:UTK), a speciality finance company focused
on technology transfer, and In Veritas Medical Diagnostics (OTCBB:IVME) a
novel medical device company, have announced that they have signed a
strategic alliance agreement.
John Fuller, Chief Executive Officer of In Veritas Medical Diagnostics
said, "We are very pleased to enter into this alliance with UTEK, as it may
accelerate the identification of promising new technology acquisition
opportunities for us. We believe that our alliance with UTEK should enable
us to enhance our intellectual property portfolio through the acquisition of
new university discoveries."
"UTEK looks forward to working with In Veritas Medical Diagnostics to
identify and transfer university and federal laboratory technology
acquisition opportunities that fit its strategic vision," commented Mark
McBride, UTEK's Vice President.
Through its strategic alliance agreements, UTEK assists companies in
enhancing their new product pipeline with the acquisition of proprietary
intellectual capital from universities and laboratory research centres.
Strategic alliance agreements are generally cancelable by either party
with thirty days advance written notice.